Evidence map›Paper›PMID 40712571›Full record

ArticleStructure (London, England : 1993)2025

Regulatory mechanisms of PP2A complex assembly driven by physicochemical differences in A-subunit isoforms.

Alexander Day, Wei Huang, Daniel Leonard, Caitlin M O'Connor, Goutham Narla, Derek J Taylor

Abstract read
In one paragraph

Article in Structure (London, England : 1993), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Mechanism-centered target discovery across glomerulonephritis phenotypes: an integrative multi-omics study.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexander DayDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Wei HuangDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Daniel LeonardDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Caitlin M O'ConnorDivision of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48105, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.
Goutham NarlaDivision of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48105, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.
Derek J TaylorDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA. Electronic address: djt36@case.edu.

Funding

Structural and molecular determinants of protein phosphatase 2A in Alzheimer's DiseaseR01CA240993 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NARLA, GOUTHAM, TAYLOR, DEREK JAMES · 2019 to 2023
$3.4M
NCI NIH HHS R01 CA240993
6 · The paper itself

Abstract

Protein phosphatase 2A (PP2A) is crucial for regulating cellular pathways, with its holoenzyme assembly affecting enzyme function and substrate selection. The PP2A holoenzyme comprises scaffold A-, regulatory B-, and catalytic C-subunits, each with various isoforms. Here, we examine structural and biochemical characteristics of the A-subunit isoforms (Aα and Aβ) and identify different biophysical properties that may promote distinct PP2A functions. Our molecular dynamics simulations and cryo-EM analyses define structural differences in the isoforms that reside primarily at the N-terminus of the A-subunit where it interfaces with regulatory B-subunits. Kinetic analyses show Aβ has a lower binding affinity in complexes with B56 subunits and exhibits unique aggregative properties as a monomeric protein. These findings suggest that the different physicochemical properties between A-subunit isoforms are key to PP2A holoenzyme assembly and function. We predict that the Aβ serves as a reservoir, ensuring that serine-threonine phosphatase activity is maintained during high regulatory demand.

Indexed as

Protein Phosphatase 2Binding SitesCatalytic DomainCryoelectron MicroscopyHoloenzymesHumansKineticsMolecular Dynamics SimulationProtein BindingProtein IsoformsProtein SubunitsHoloenzymesProtein IsoformsProtein Phosphatase 2Protein SubunitsA-subunitAαAβcryo-EMisoformphosphatasePP2APPP2R1APPP2R1Bscaffold

Identifiers

PMID40712571
PMCPMC12313256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.